Lab Sciences
Top stories summarized by our editors
3/21/2019

A survey found that fewer than half of 563 respondents were aware of the CDC's recommendation that people born from 1945 to 1965 should receive hepatitis C virus testing. The findings were published in the Southern Medical Journal.

More Summaries:
CDC
3/21/2019

Democratic Republic of Congo health officials said 44 new cases of Ebola virus infection have been reported in the past few days, and one case has been confirmed in the city of Bunia, whose population is almost 1 million. UNICEF reported a decline in the number of cases involving children, particularly those younger than 5.

More Summaries:
Ebola, UNICEF
3/21/2019

Levels of FVIII-EC50 have the potential to be used to predict response to preventive factor VIII therapy among patients with severe hemophilia A, according to a study in the European Journal of Pharmaceutical Sciences. "Tests addressing personal hallmarks other than FVIII activity to predict bleeding phenotype in patients with haemophilia would offer considerable clinical benefits," the study team wrote.

Full Story:
Hemophilia News Today
3/20/2019

British researchers discovered that the epigenetic protein EZH2 could become a novel therapeutic target in patients with acute myeloid leukemia. EZH2 delays disease development until the disease is established, but after that point it promotes tumor growth.

3/20/2019

McMaster University's Biointerfaces Institute, based in Ontario, signed a research collaboration with Q BioMed and its technology partner Mannin Research to develop a GDF15 biomarker diagnostic kit that can be used to monitor glaucoma severity and progression. The goal is to develop prototype assays ideal for point-of-care testing.

Full Story:
Seeking Alpha
3/20/2019

Oxford BioDynamics agreed to join a clinical trial conducted by Imperial College London that aims to evaluate different methods of prostate cancer screening. As part of the deal, Oxford will use its EpiSwitch diagnostic biomarker assay to assess trial participants for prostate cancer.

Full Story:
Compelo
3/20/2019

Walgreens Boots Alliance signed a deal to sell in the UK Concepta Diagnostics' CE-marked myLotus at-home fertility monitoring system, which consists of an app and fertility monitor designed to help women measure their luteinizing hormone levels at home, calculate their most fertile days and determine whether they are pregnant. Concepta Chair Matthew Walls said the company, in partnership with Walgreens, expects to launch myLotus in other EU markets in the coming months.

Full Story:
MobiHealthNews
3/20/2019

Oncimmune Holdings entered into an all-share deal to acquire German firm Protagen for over $4.6 million. Oncimmune CEO Adam Hill said the deal "will accelerate Oncimmune's product discovery process, will grow our library of known and novel immunogenic proteins, and will underpin the group's ability to deliver value through the development of complementary diagnostics, a key component of our three-year forward strategy."

Full Story:
Morningstar
3/20/2019

Everstone Group, through its health care platform Everlife, acquired an undisclosed stake in CPC Diagnostics, an India-based medical device company that exports products to Middle East and European countries.

Full Story:
The Times of India
3/19/2019

Taking simple steps to reduce energy, water and hazardous chemical use and being mindful of the environmental effects of daily laboratory activities can turn a clinical laboratory into a more sustainable space, writes Allison Paradise, CEO of My Green Lab. Turning off equipment when not in use, equipping faucets with low-flow aerators, using glassware instead of disposable plastic items and eliminating use of mercury are some changes clinical labs can adopt to reduce environmental impact.